Thomas Frieden
Showing 1–4 of 4 transcripts.
- Milken Institute1h 0m
How Improved Health and Longer Lives Drive Global Prosperity (updated)
Thomas Frieden, Jonathan Gluck, Carole Roan Gresenz, Michael Harsh, Peter Margolis, Ceci Connolly, Mike Harsh
Six healthcare experts from institutions including the CDC, PwC, and Heritage Provider Network convened at Milk and Palooza to analyze how innovation drives economic growth while challenging myths about cost containment. The panel highlighted that targeted interventions like immunizations and telehealth generate substantial societal returns, contrasting these successes against a system where $2.8 trillion in annual spending is hindered by fee-for-service models that prioritize volume over outcomes. By advocating for data-driven "healthy defaults" and the industrialization of care, the discussion emphasized that political shifts toward value-based payment and preventive measures are essential to improving productivity and reducing unnecessary expenditures.
- Milken Institute1h 11m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science (updated II)
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken, Mike Milken, Tom Frieden, Andy Van Eschenbach, Jack Andreyka
A comprehensive analysis of global bioscience reveals a dramatic increase in life expectancy and major breakthroughs in disease eradication, such as the near-elimination of polio and HIV management through programs like PEPFAR. Despite these successes, the sector faces a critical funding crisis where declining NIH grant success rates and inflation-adjusted budget cuts threaten the pipeline of young researchers and the translation of genetic discoveries into new treatments. Strategic initiatives like the Brain Initiative, precision medicine efforts, and the shift toward prevention are now essential to address rising chronic disease burdens and sustain the bioscience industry as a primary driver of US economic growth.
- Milken Institute1h 2m
How Improved Health and Longer Lives Drive Global Prosperity
Thomas Frieden, Jonathan Gluck, Carole Roan Gresenz, Michael Harsh, Peter Margolis, Ceci Connolly
A panel of experts from the CDC, GE Health Care, and leading academic institutions demonstrated that shifting from fee-for-service models to accountable care systems can simultaneously improve population health and reduce long-term costs through specific innovations like immunizations and diagnostic imaging. By leveraging data standardization, prize challenges, and telehealth pilots, the session highlighted how eliminating clinical variation and preventing disease rather than treating it generates billions in annual societal savings. The discussion concluded that political and payment reforms, rather than technological limitations, remain the primary obstacles to fully realizing these economic benefits and fostering entrepreneurial growth through universal insurance access.
- Milken Institute1h 12m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken
The bioscience forum highlighted the sector's massive contribution to increased global life expectancy and economic growth while emphasizing that flat budgets and inflation have critically reduced NIH grant success rates to below 20%. Distinguished leaders such as Francis Collins and Tom Frieden warned that sustained funding cuts and a 90% treatment-versus-prevention spending imbalance threaten American innovation and the careers of young researchers. Despite these financial constraints, the event underscored significant breakthroughs in areas like genomic medicine and disease eradication, with panelists urging renewed investment to maintain global health leadership and drive future discoveries.